ATE300611T1 - Auf rezeptorgrundlage arbeitende screening- verfahren für protein wechselwirkungen - Google Patents
Auf rezeptorgrundlage arbeitende screening- verfahren für protein wechselwirkungenInfo
- Publication number
- ATE300611T1 ATE300611T1 AT01960237T AT01960237T ATE300611T1 AT E300611 T1 ATE300611 T1 AT E300611T1 AT 01960237 T AT01960237 T AT 01960237T AT 01960237 T AT01960237 T AT 01960237T AT E300611 T1 ATE300611 T1 AT E300611T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor
- binding
- screening methods
- protein interactions
- based screening
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/06—Uses of viruses as vector in vitro
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00201771 | 2000-05-22 | ||
PCT/EP2001/005916 WO2001090188A2 (en) | 2000-05-22 | 2001-05-22 | Receptor-based interaction trap |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE300611T1 true ATE300611T1 (de) | 2005-08-15 |
Family
ID=8171515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01960237T ATE300611T1 (de) | 2000-05-22 | 2001-05-22 | Auf rezeptorgrundlage arbeitende screening- verfahren für protein wechselwirkungen |
Country Status (8)
Country | Link |
---|---|
US (2) | US7855270B2 (de) |
EP (2) | EP1612221A3 (de) |
JP (1) | JP4756813B2 (de) |
AT (1) | ATE300611T1 (de) |
AU (2) | AU2001281784B2 (de) |
CA (1) | CA2407872C (de) |
DE (1) | DE60112282T2 (de) |
WO (1) | WO2001090188A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60239097D1 (de) | 2001-03-02 | 2011-03-17 | Gpc Biotech Ag | Drei-hybrid-assaysystem |
WO2003004643A2 (en) | 2001-07-03 | 2003-01-16 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Reversed mammalian protein-protein interaction trap |
GB201103453D0 (en) | 2011-03-01 | 2011-04-13 | Vib Vzw | Kinase substrate sensor |
US9746470B2 (en) * | 2011-05-09 | 2017-08-29 | Whitehead Institute For Biomedical Research | Chaperone interaction assays and uses thereof |
EP2823044B1 (de) | 2012-03-06 | 2017-12-06 | VIB vzw | Membran-spankinase-fusionsprotein und verwendungen davon |
WO2013174999A1 (en) | 2012-05-24 | 2013-11-28 | Vib Vzw | Virus-like particle based protein-protein interaction |
GB201504859D0 (en) | 2015-03-23 | 2015-05-06 | Vib Vzw | Viral particle based small molecule-protein interaction trap |
GB201909491D0 (en) * | 2019-07-01 | 2019-08-14 | Governing Council Of The Univ Of Toronto | Detection of protein to protein interactions |
CN115210381A (zh) * | 2019-12-17 | 2022-10-18 | 奥里尼斯生物科学股份有限公司 | 新型降解相关相互作用的检测 |
AU2020404918A1 (en) * | 2019-12-17 | 2022-07-07 | Orionis Biosciences BV | Detection of molecular interactions |
AU2022349077A1 (en) * | 2021-09-22 | 2024-03-28 | Sonoma Biotherapeutics, Inc. | Il5ra cell surface markers |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1892296A1 (de) | 1988-09-02 | 2008-02-27 | Dyax Corporation | Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen |
DK0585287T3 (da) | 1990-07-10 | 2000-04-17 | Cambridge Antibody Tech | Fremgangsmåde til fremstilling af specifikke bindingsparelementer |
CZ206195A3 (en) | 1993-02-12 | 1996-04-17 | Univ Leland Stanford Junior | Controlled transcription of target genes and other biological materials |
US5521066A (en) * | 1993-09-13 | 1996-05-28 | Bristol-Myers Squibb Company | Periplasmic membrane-bound system for detecting protein-protein interactions |
US5935797A (en) * | 1994-06-16 | 1999-08-10 | Stanford University | Interaction of MHC Class II proteins with members of the PCNA family of proteins |
US5716622A (en) * | 1995-01-06 | 1998-02-10 | The Rockefeller University | Functionally active regions of signal transducer and activators of transcription |
US5712149A (en) * | 1995-02-03 | 1998-01-27 | Cell Genesys, Inc. | Chimeric receptor molecules for delivery of co-stimulatory signals |
US5637463A (en) | 1995-05-04 | 1997-06-10 | Hoffmann-La Roche Inc. | Method to detect protein-protein interactions |
GB9511935D0 (en) | 1995-06-13 | 1995-08-09 | Smithkline Beecham Plc | Novel compound |
SE9503151D0 (sv) | 1995-09-13 | 1995-09-13 | Bioinvent Internatioal Ab | Combined ligand and receptor display |
US5972621A (en) * | 1995-11-27 | 1999-10-26 | Millennium Pharmaceuticals, Inc. | Methods of identifying compounds that modulate body weight using the OB receptor |
AU1406497A (en) | 1995-12-06 | 1997-06-27 | Schering Corporation | Mutational variants of mammalian ob gene proteins |
US7063958B1 (en) | 1996-01-16 | 2006-06-20 | The Rockefeller University | Nucleic acids db, the receptor for leptin |
EP0882128A1 (de) * | 1996-02-23 | 1998-12-09 | Ariad Pharmaceuticals, Inc. | Auf zellen basierendes testverfahren |
EP0883686A1 (de) | 1996-02-26 | 1998-12-16 | Morphosys Gesellschaft für Proteinoptimierung mbH | Methode zur identifikation von nukleinsäuren für zwei oder mehreren interagierenden (poly)peptiden |
CA2257240A1 (en) | 1996-06-06 | 1997-12-11 | Smithkline Beecham P.L.C. | Fragments of leptin (ob protein) |
US6001816A (en) * | 1996-06-20 | 1999-12-14 | Merck & Co., Inc. | Gene therapy for leptin deficiency |
US5843697A (en) * | 1996-07-17 | 1998-12-01 | University Of Medicine And Dentistry Of New Jersey | Cells expressing IL-10 receptor and the CRFB4 gene product, an IL-10 receptor accessory protein |
US5776689A (en) * | 1996-07-19 | 1998-07-07 | The Regents Of The University Of California | Protein recruitment system |
CN1230966A (zh) | 1996-09-20 | 1999-10-06 | 赫彻斯特股份公司 | 勒帕素拮抗剂在用于治疗ii型糖尿病胰岛素耐受性中的用途 |
EP0951564A1 (de) | 1996-11-01 | 1999-10-27 | Smithkline Beecham Plc | Verfahren zum nachweis zur modulation der effekte vom obesitäts-(ob)-protein |
CA2196496A1 (en) * | 1997-01-31 | 1998-07-31 | Stephen William Watson Michnick | Protein fragment complementation assay for the detection of protein-protein interactions |
US6294330B1 (en) * | 1997-01-31 | 2001-09-25 | Odyssey Pharmaceuticals Inc. | Protein fragment complementation assays for the detection of biological or drug interactions |
US6342345B1 (en) * | 1997-04-02 | 2002-01-29 | The Board Of Trustees Of The Leland Stanford Junior University | Detection of molecular interactions by reporter subunit complementation |
AU8405998A (en) * | 1997-07-15 | 1999-02-10 | Aurora Biosciences Corporation | Compositions and methods for identifying modulators of transducisomes, a ew class of therapeutic targets |
US5885779A (en) * | 1997-09-09 | 1999-03-23 | University Of British Columbia | Repressed trans-activator system for characterization of protein-protein interactions |
CA2320226A1 (en) | 1998-02-11 | 1999-08-19 | Beth Israel Deaconess Medical Center | Methods and compositions for modulating leptin activity |
AU756617B2 (en) | 1998-07-28 | 2003-01-16 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Leptin-mediated gene-induction |
JP2002522031A (ja) * | 1998-07-28 | 2002-07-23 | フラームス・インテルウニフェルシタイル・インスティチュート・フォール・ビオテヒノロヒー | 真核細胞ベースの遺伝子相互作用クローニング |
AU5143099A (en) * | 1998-07-30 | 2000-02-21 | Universite De Montreal | Protein fragment complementation assays for the detection of biological or drug interactions |
ES2305093T3 (es) * | 2000-06-13 | 2008-11-01 | Bayer Healthcare Ag | Regulacion de la serina proteasa transmembrana humana. |
AU2067202A (en) | 2000-11-14 | 2002-05-27 | Vlaams Interuniv Inst Biotech | Functional fragment of the lectine receptor |
CA2437265A1 (en) | 2001-02-06 | 2002-08-15 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Modified leptin with reduced immunogenicity |
CA2585549A1 (en) | 2004-11-18 | 2006-05-26 | Vib Vzw | Novel type leptin receptor antagonist |
-
2001
- 2001-05-22 DE DE60112282T patent/DE60112282T2/de not_active Expired - Lifetime
- 2001-05-22 AU AU2001281784A patent/AU2001281784B2/en not_active Expired
- 2001-05-22 WO PCT/EP2001/005916 patent/WO2001090188A2/en active IP Right Grant
- 2001-05-22 JP JP2001586999A patent/JP4756813B2/ja not_active Expired - Lifetime
- 2001-05-22 AT AT01960237T patent/ATE300611T1/de active
- 2001-05-22 EP EP05016201A patent/EP1612221A3/de not_active Withdrawn
- 2001-05-22 EP EP01960237A patent/EP1283878B1/de not_active Expired - Lifetime
- 2001-05-22 AU AU8178401A patent/AU8178401A/xx active Pending
- 2001-05-22 CA CA2407872A patent/CA2407872C/en not_active Expired - Lifetime
-
2002
- 2002-11-22 US US10/303,157 patent/US7855270B2/en not_active Expired - Lifetime
-
2009
- 2009-12-14 US US12/653,484 patent/US8003757B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20030100021A1 (en) | 2003-05-29 |
CA2407872C (en) | 2013-11-12 |
EP1283878B1 (de) | 2005-07-27 |
WO2001090188A3 (en) | 2002-06-13 |
US7855270B2 (en) | 2010-12-21 |
US20100173408A1 (en) | 2010-07-08 |
CA2407872A1 (en) | 2001-11-29 |
AU8178401A (en) | 2001-12-03 |
EP1612221A2 (de) | 2006-01-04 |
WO2001090188A9 (en) | 2002-09-19 |
DE60112282T2 (de) | 2006-04-20 |
JP2003533998A (ja) | 2003-11-18 |
EP1283878A2 (de) | 2003-02-19 |
WO2001090188A2 (en) | 2001-11-29 |
EP1612221A3 (de) | 2008-07-23 |
JP4756813B2 (ja) | 2011-08-24 |
US8003757B2 (en) | 2011-08-23 |
DE60112282D1 (de) | 2005-09-01 |
AU2001281784B2 (en) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE300611T1 (de) | Auf rezeptorgrundlage arbeitende screening- verfahren für protein wechselwirkungen | |
ATE504599T1 (de) | Zur aktivierung von rezeptoren fähige fusionspolypeptide | |
ATE373012T1 (de) | An caml bindender lymphozyteoberflächenrezeptor, nukleinsäuren die dafür kodieren und verfahren zur verwendung | |
PT1133559E (pt) | Receptor acoplato a proteina g orfao humano, rup3 | |
DE602005019495D1 (de) | Ligand für den Formylpeptidrezeptorähnlichen- 2 (FPRL2) G Protein gekoppelten Rezeptor und dessen Anwendung | |
NO2011003I1 (no) | Dimensk fusjonsprotein bestående av de ligandbindende cfomener av de ekstacellulære deler av human type I interieukm-1 reseptor (IL-1R1) og IL-1 reseptor hjelpeprotein bundet (IL-I-RAcP) bundet i tinje til Fc-delen av humant IgG | |
DK1011704T3 (da) | Tumornekrose-faktor-receptor-afledte peptid-analiger | |
MX2007015931A (es) | Receptores de sabor dulce-umami y umami-dulce humanos quimericos. | |
DE602004022390D1 (de) | Verbesserte fc-fusionsproteine | |
TNSN07040A1 (fr) | Proteines de fusion de rage et methodes d'utilisation | |
DE60042617D1 (de) | Verfahren zur therapeutischen Verwendung von löslichen rezeptoren BR43X2 | |
DK0517895T3 (da) | Kimæriske kæder til receptorforbundne signaltransduktionsveje | |
SG171670A1 (en) | Rage fusion proteins, formulations, and methods of use thereof | |
ATE308609T1 (de) | Pth rezeptor und testverfahren unter verwendung desselben | |
DE69840303D1 (de) | Neue g-protein gekoppelte rezeptorproteine | |
ATE462977T1 (de) | Verfahren zum nachweis von autoimmunantikörpern gegen den tsh-rezeptor und neue tsh- rezeptorchimären | |
ATE354802T1 (de) | Methoden zum screening knochenmorphogenetishemimetika | |
WO2001085930A3 (en) | Methods and compounds for modulating melanocortin receptor ligand binding and activity | |
DE69417223D1 (de) | Ein menschlicher t-zell rezeptor der protein g-gekoppelte rezeptor familie | |
Lodge et al. | Identification and characterization of CEPU-Se—a secreted isoform of the IgLON family protein, CEPU-1 | |
SE9701010D0 (sv) | Antibody | |
DE60329116D1 (de) | Herstellung von homotrimeren fusionsproteinen | |
ATE491030T1 (de) | Rekombinante expression von rubella e1 hüllenproteinvarianten als chaperon- fusionsproteine und seine verwendung zum nachweis von anti-rubella antikörper | |
DK1317564T3 (da) | Screeningsfremgangsmåder til at identificere G-proteiner og andre forbindelser, som modulerer phosphodiesterase (PDE)-aktiviteten | |
EP1588171A2 (de) | Verbessertes verfahren zum screenen mit beta-arrestin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1283878 Country of ref document: EP |